Kestra Medical Technologies, Ltd. Common Stock Price & Performance (KMTS)

Kestra Medical Technologies has successfully closed its upsized IPO, raising $202 million before deducting costs. The company, known for its wearable cardiac devices, began trading under the ticker KMTS on Nasdaq. Initial shares were priced at $17, with underwriters fully exercising their over-allotment option.12

Kestra Medical Technologies saw its shares open at $22.95 on March 6, significantly above its $17 IPO price. The offering included 11.88 million shares, with an option for underwriters to purchase an additional 1.78 million. The company specializes in innovative cardiovascular monitoring solutions.342

Kestra Medical Technologies, focusing on wearable cardiac monitors, raised $202 million in its IPO. The funds will support sales expansion and R&D. Its Assure defibrillator, FDA-approved since 2021, serves a growing market for cardiac care, with over 17,000 users to date.562